Abbott recalls some ready-to-feed baby formula liquid products including Similac

Published On 2022-10-15 06:45 GMT   |   Update On 2022-10-15 06:45 GMT

New Delhi: Abbott Laboratories said on Friday it was recalling some ready-to-feed baby formula liquid products including Similac-branded items due to inadequate sealing of some bottle caps.The recall, which equates to less than one day's worth of infant formula used in the United States, is not expected to impact the overall formula supply, Abbott said in a statement.Abbott has been at the...

Login or Register to read the full article

New Delhi: Abbott Laboratories said on Friday it was recalling some ready-to-feed baby formula liquid products including Similac-branded items due to inadequate sealing of some bottle caps.

The recall, which equates to less than one day's worth of infant formula used in the United States, is not expected to impact the overall formula supply, Abbott said in a statement.

Abbott has been at the center of a baby formula shortage in the United States that earlier this year sent parent scrambling for supplies.

The recall of baby formula made at Abbott's Michigan plant following complaints of bacterial infection in February exacerbated its shortage in the United States.

Read also: Abbott labs India unit concludes recall of baby formula products manufactured at Michigan facility

To boost supplies, the U.S. government temporarily allowed foreign imports from companies such as Reckitt Benckiser and Nestle.

Supplies have been improving in recent months, according to large retailers such as Walmart, but the government has continued to allow imports to stock up shelves.

Read also: Abbott restarts Similac infant formula production at Michigan facility

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News